We represented a group purchasing organization in a strategic relationship with a medical manufacturing company and establishment of a Chinese representative office to procure all types of medical and consumer products from China to save member organizations millions of dollars each year.
Representation of a Group Purchasing Organization in a Strategic International Transaction
You Also May Be Interested In:
Represented Life Technologies Corp. in a Federal Circuit Appeal stemming from a 2017 Patent Trial and Appeal Board (PTAB) decision in a covered business method proceeding (CBM). Michael Kiklis represented Life Technologies in two covered business method proceedings: one was filed in 2014 and the other was filed in 2015. Life Technologies prevailed in both proceedings with the PTAB finding that all challenged claims of Unisone Strategic IP Inc.’s inventory management patent recited ineligible subject matter pursuant to 35 U.S.C. § 101. This appeal involved the second CBM. Unisone chose not to appeal the first CBM. The Federal Circuit heard oral argument on December 4, 2018, and then affirmed the PTAB’s decision less than one week later.
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
Represented Wholesale, LLC and Wholesale Express, LLC in its sale to RumbleOn, Inc (Nasdaq: RMBL) for $16 million in cash and 1,317,329 in shares of RumbleOn Series B Preferred Stock